531599 Stock Overview
FDC Limited manufactures and markets pharmaceutical products in India and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 5/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
NewNotes are coming soon
FDC Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹256.60 |
| 52 Week High | ₹319.00 |
| 52 Week Low | ₹229.15 |
| Beta | 0.21 |
| 1 Month Change | -5.47% |
| 3 Month Change | -16.06% |
| 1 Year Change | -12.88% |
| 3 Year Change | 7.05% |
| 5 Year Change | -10.33% |
| Change since IPO | 5,902.34% |
Recent News & Updates
Recent updates
Shareholder Returns
| 531599 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 0.7% | -1.2% | -1.1% |
| 1Y | -12.9% | -8.1% | -3.4% |
Return vs Industry: 531599 underperformed the Indian Pharmaceuticals industry which returned -8.7% over the past year.
Return vs Market: 531599 underperformed the Indian Market which returned -4.1% over the past year.
Price Volatility
| 531599 volatility | |
|---|---|
| 531599 Average Weekly Movement | 3.7% |
| Pharmaceuticals Industry Average Movement | 4.7% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in IN Market | 9.0% |
| 10% least volatile stocks in IN Market | 3.4% |
Stable Share Price: 531599 is less volatile than 75% of Indian stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: 531599's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1936 | 6,336 | Nandan Chandavarkar | https://www.fdcindia.com |
FDC Limited manufactures and markets pharmaceutical products in India and internationally. The company offers specialized formulations for various therapeutic segments, including anti-infective, gastrointestinal, ophthalmological, vitamins/minerals/dietary supplements, cardiac, anti-diabetes, respiratory, gynaecology, dermatology, analgesics, and others; and oral rehydration salts. It provides specialized formulations primarily under the Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl, and Mycoderm brand names.
FDC Limited Fundamentals Summary
| 531599 fundamental statistics | |
|---|---|
| Market Cap | ₹42.57b |
| Earnings (TTM) | ₹1.69b |
| Revenue (TTM) | ₹16.22b |
25.2x
P/E Ratio2.6x
P/S RatioIs 531599 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 531599 income statement (TTM) | |
|---|---|
| Revenue | ₹16.22b |
| Cost of Revenue | ₹6.23b |
| Gross Profit | ₹9.99b |
| Other Expenses | ₹8.31b |
| Earnings | ₹1.69b |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
Feb 09, 2023
| Earnings per share (EPS) | 10.17 |
| Gross Margin | 61.59% |
| Net Profit Margin | 10.40% |
| Debt/Equity Ratio | 0.03% |
How did 531599 perform over the long term?
See historical performance and comparison